Home

Accretion Pharmaceuticals PE Ratio

Image

Accretion Pharmaceuticals Ltd

NSE: AccretionPha.

PE

10.6

Last updated on: Jul 21, 2025

Key Highlights

  • The P/E Ratio of Accretion Pharmaceuticals Ltd is 10.6 as of 21 Jul 25 .
  • The P/E Ratio of Accretion Pharmaceuticals Ltd is 0 as of March 2024 .
  • The Latest Trading Price of Accretion Pharmaceuticals Ltd is ₹ 64.7 as of 22 Jul 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.2 to 40.1 in 5 years. This represents a CAGR of 13.60%.
  • The PE Ratio of Automobile industry is 16.9. The PE Ratio of Finance industry is 26.8. The PE Ratio of IT - Software industry is 27.0. The PE Ratio of Pharmaceuticals industry is 33.5. The PE Ratio of Retail industry is 109.6. The PE Ratio of Textiles industry is 27.9 in 2025.
Image

Accretion Pharmaceuticals Ltd

NSE: AccretionPha.

PE

-

Last updated on: Invalid Date

Company Fundamentals for Accretion Pharmaceuticals Ltd

Image

Accretion Pharmaceuticals Ltd

NSE: AccretionPha.

Share Price

₹ 64.7

0.00 (0.00%)

stock direction

Last updated on: Jul 22, 2025

Market Price of Accretion Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Accretion Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Jul 202564.7
18 Jul 202564.3
17 Jul 202565.85
16 Jul 202564.75
15 Jul 202565
14 Jul 202566.9
11 Jul 202563.75
10 Jul 202565.6
09 Jul 202566.05
08 Jul 202566.95

BlinkX Score for Accretion Pharmaceuticals Ltd

Asset Value vs Market Value of Accretion Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PE Ratio of Accretion Pharmaceuticals Ltd Explained

71.92

Market cap

1

Earnings

10.6X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Accretion Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Accretion Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Accretion Pharmaceuticals Ltd

No data available

* All values are in %

About Accretion Pharmaceuticals Ltd

  • Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products.
  • Thus, the foundation of 'Accretion Pharmaceuticals' was laid down, which was started as a Partnership Firm in the name of 'M/s Accretion Pharmaceuticals', pursuant to a deed of partnership dated December 18, 2012. The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in year 2014.
  • Thereafter, the Partnership Firm was converted into a Limited Company in the name of 'Accretion Pharmaceuticals Limited' and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.

Accretion Pharmaceuticals Ltd News Hub

NSE SME Accretion Pharmaceuticals' IPO ends with subscription of 7.31 times

The initial public offer (IPO) of Accretion Pharmaceuticals received bids for 2,00,06,400 shares as

Read more

19 May 25

NSE SME Accretion Pharma stumbles on market debut

The scrip was listed at 79, a discount of 21.78% over the initial public offer (IPO) price. The stoc

Read more

21 May 25

Accretion Pharmaceuticals to discuss results

Accretion Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 June 20

Read more

05 Jun 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions